基于索赔数据的非医保患者EVAR后再干预监测
本研究将VQI注册中2011-2015年接受EVAR的患者与纽约州全支付方索赔数据库链接,比较医保资格患者与非资格患者的再干预率。共纳入1285例患者,中位随访16个月,3年再干预率为21%,医保资格与非资格患者再干预率相似(19% vs 20%),调整后结果一致。
要点
- 非医保患者占EVAR人群的14%,其再干预率与医保资格患者相似。
- 利用全支付方行政索赔数据可监测所有年龄段EVAR后再干预。
- 3年再干预率为21%,可作为EVAR质量评价指标。
核心结论
- 再干预可通过医保和非医保支付方的行政索赔数据进行监测,是所有年龄段EVAR后的重要结局指标。
- 老年医保资格个体与尚未符合资格个体的再干预率似乎相似。
研究设计与样本
- 研究链接VQI注册(2011-2015年EVAR患者)与纽约州全支付方索赔数据库,患者层面匹配率96%。
- 比较医保资格(≥65岁或透析)与非资格(<65岁且非透析)患者,主要结局为再干预,采用Cox回归和倾向评分匹配调整。
- 共纳入1285例患者,中位随访16个月(范围1-57个月)。
主要发现
- 平均年龄74岁,79%为男性,84%手术为择期。
- 非医保资格患者占14%,医保资格患者占86%。
- 医保资格患者男性比例较低(77% vs 91%;P < .001),吸烟史比例较低(79% vs 93%;P < .001),非择期手术比例较低(15% vs 23%;P = .013)。
- 3年Kaplan-Meier再干预率为21%。
- 医保资格与非资格患者再干预率相似(19% vs 20%,log-rank P = .199;未调整HR 0.75,95%CI 0.49-1.16;调整HR 0.82,95%CI 0.50-1.34;倾向匹配HR 0.70,95%CI 0.36-1.37)。
临床怎么用
- 可利用全支付方行政索赔数据监测EVAR后再干预,覆盖所有年龄段和保险类型患者。
- 再干预率可作为EVAR质量改进的结局指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Many patients who undergo endovascular aortic aneurysm repair (EVR) also undergo repeat procedures, or reinterventions, to address suboptimal device performance and prevent aneurysm rupture. Quality improvement initiatives measuring reintervention after EVR has focused on fee-for-service Medicare patients. However, because patients aged less than 65 years and those with Medicare Advantage represent an important growing subgroup, we used a novel approach leveraging a state data source that captures patients of all ages and with all types of insurance. METHODS: We identified patients who underwent EVR (2011-2015) within the Vascular Quality Initiative registry and were also listed in the Statewide Planning and Research Cooperative System all-payer claims database of New York. We linked patients in the Vascular Quality Initiative to their Statewide Planning and Research Cooperative System claims file at the patient level with a 96% match rate. We compared outcomes between fee-for-service Medicare eligible, defined as age 65 or older or on dialysis, versus ineligible patients, defined as those younger than 65 and not on dialysis. Our primary outcome was reintervention. We used Cox proportional hazards regression and propensity score matching for risk adjustment. RESULTS: We studied 1285 patients with a median follow-up of 16 months (range, 1-57 months). The mean age was 74 years, 79% were male, and 84% of procedures were elective. Nearly one in six patients were not Medicare eligible (14%), and the remainder (86%) were Medicare eligible. Medicare-eligible patients were less likely to be male (77% vs 91%; P < .001), have a history of smoking (79% vs 93%; P < .001), and have a nonelective procedure (15% vs 23%; P = .013). The 3-year Kaplan-Meier rate of reintervention was 21%. We found similar rates of reintervention between Medicare-eligible patients and those who were not (19% vs 20%, log-rank P = .199; unadjusted hazard ratio [HR], 0.75; 95% confidence interval [CI], 0.49-1.16). This finding persisted in both the adjusted and propensity-matched analyses (adjusted HR, 0.82; 95% CI, 0.50-1.34; propensity-matched HR, 0.70; 95% CI, 0.36-1.37). CONCLUSIONS: Reintervention can be monitored using administrative claims from both Medicare and non-Medicare payers, and serve as an important outcome metric after EVR in patients of all ages. The rate of reintervention seems to be similar between older, Medicare-eligible individuals, and those who are not yet eligible.
引用
- Columbo JA, Sedrakyan A, Mao J, et al. Claims-based surveillance for reintervention after endovascular aneurysm repair among non-Medicare patients. J Vasc Surg. 2019. PMID: 30922744. doi:10.1016/j.jvs.2018.11.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。